10/15/2018 /
Unplanned pregnancy may double the risk of spontaneous fetal loss in women with epilepsy.
10/12/2018 /
A dysfunction of the GABAergic system together with defective sodium channels can contribute to a general reduction of inhibitory efficacy in Dravet brain, suggesting that GABAA receptors could be a target for new therapies.
10/12/2018 /
This research will provide a voice-based user interface for an existing Epilepsy Patient Portal, allowing people to co-author their own electronic patient record (EPR).
10/12/2018 /
These findings suggest focal temporal and frontal lobe epilepsies were associated with impaired theory of mind. This may have implications for differential cognitive-behavioral interventions based on epilepsy type.
10/11/2018 /
Cognizance Biomarkers announced that the U.S. Patent and Trademark Office issued a new patent providing further protection for its novel neuro-inflammatory biomarkers for the diagnosis, management, and treatment of epileptic seizures.
10/11/2018 /
An international team of scientists, researchers and interoperability experts will evaluate biosensors that can track an individual’s physiology, behavior, and environment to improve seizure prediction.
10/10/2018 /
LivaNova says a new cost analysis found that Vagus Nerve Stimulation Therapy (VNS Therapy) System results in lower resource utilization and lower cost for drug-resistant epilepsy patients when compared to continued treatment with anti-epileptic drugs.
10/10/2018 /
The report shows that there continues to be a steady flow of potential antiepileptic drugs progressing to clinical development.
10/08/2018 /
Rapamycin therapy exhibits positive effects on epileptic seizures in cases of TSC in 1-2 ?years but these positive effects on seizure control of rapamycin therapy decline after the second year.
